Catalogo Articoli (Spogli Riviste)

HELP
ATTENZIONE: attualmente gli articoli Current Contents (fonte ISI) a partire dall'anno 2002 sono consultabili sulla Risorsa On-Line

Le informazioni sugli articoli di fonte ISI sono coperte da copyright

La ricerca find articoli where soggetti phrase all words 'DOPAMINE RECEPTOR-BINDING' sort by level,fasc_key/DESCEND, pagina_ini_num/ASCEND ha restituito 42 riferimenti
Selezionare un intervallo

Per ulteriori informazioni selezionare i riferimenti di interesse.

    1. Viyoch, J; Ohdo, S; Yukawa, E; Higuchi, S
      Dosing time-dependent tolerance of catalepsy by repetitive administration of haloperidol in mice

      JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS
    2. Allan, AM; Galindo, R; Chynoweth, J; Engel, SR; Savage, DD
      Conditioned place preference for cocaine is attenuated in mice over-expressing the 5-HT3 receptor

      PSYCHOPHARMACOLOGY
    3. Strakowski, SM; DelBello, MP; Adler, C; Cecil, KM; Sax, KW
      Neuroimaging in bipolar disorder

      BIPOLAR DISORDERS
    4. Taylor, SF; Koeppe, RA; Tandon, R; Zubieta, JK; Frey, KA
      In vivo measurement of the vesicular monoamine transporter in schizophrenia

      NEUROPSYCHOPHARMACOLOGY
    5. Ishizu, K; Smith, DF; Bender, D; Danielsen, E; Hansen, SB; Wong, DF; Cumming, P; Gjedde, A
      Positron emission tomography of radioligand binding in porcine striatum invivo: Haloperidol inhibition linked to endogenous ligand release

      SYNAPSE
    6. Kraxner, J; Hubner, H; Gmeiner, P
      Azepino- and diazepinoindoles: Synthesis and dopamine receptor binding profiles

      ARCHIV DER PHARMAZIE
    7. Sanchez-Pernaute, R; Kunig, G; Alba, AD; de Yebenes, JG; Vontobel, P; Leenders, KL
      Bradykinesia in early Huntington's disease

      NEUROLOGY
    8. Stoll, AL; Renshaw, PF; Yurgelun-Todd, DA; Cohen, BM
      Neuroimaging in bipolar disorder: What have we learned?

      BIOLOGICAL PSYCHIATRY
    9. Cohen, RM; Nordahl, TE; Semple, WE; Pickar, D
      The brain metabolic patterns of clozapine- and fluphenazine-treated femalepatients with schizophrenia: Evidence of a sex effect

      NEUROPSYCHOPHARMACOLOGY
    10. Yu, JA; Kallstrom, L; Wiesel, FA; Johnson, AE
      Neurochemical changes in the entopeduncular nucleus and increased oral behavior in rats treated subchronically with clozapine or haloperidol

      SYNAPSE
    11. Dajas-Bailador, FA; Asencio, M; Bonilla, C; Scorza, MC; Echeverry, C; Reyes-Parada, M; Silveira, R; Protais, P; Russell, G; Cassels, BK; Dajas, F
      Dopaminergic pharmacology and antioxidant properties of pukateine, a natural product lead for the design of agents increasing dopamine neurotransmission

      GENERAL PHARMACOLOGY
    12. Tsukada, H
      Delivery of radioligands for positron emission tomography (PET) in the central nervous system

      ADVANCED DRUG DELIVERY REVIEWS
    13. Bigliani, V; Pilowsky, LS
      In vivo neuropharmacology of schizophrenia

      BRITISH JOURNAL OF PSYCHIATRY
    14. Cavanagh, JTO; Shajahan, PM
      Increasing rates of hospital admission for men with major mental illnesses: data from Scottish mental health units, 1980-1995

      ACTA PSYCHIATRICA SCANDINAVICA
    15. HALL H; HALLDIN C; FARDE L; SEDVALL G
      WHOLE HEMISPHERE AUTORADIOGRAPHY OF THE POSTMORTEM HUMAN BRAIN

      Nuclear medicine and biology
    16. ODONNELL P; GRACE AA
      DYSFUNCTIONS IN MULTIPLE INTERRELATED SYSTEMS AS THE NEUROBIOLOGICAL BASES OF SCHIZOPHRENIC SYMPTOM CLUSTERS

      Schizophrenia bulletin
    17. ITO H; HIETALA J; BLOMQVIST G; HALLDIN C; FARDE L
      COMPARISON OF THE TRANSIENT EQUILIBRIUM AND CONTINUOUS-INFUSION METHOD FOR QUANTITATIVE PET ANALYSIS OF [C-11] RACLOPRIDE BINDING

      Journal of cerebral blood flow and metabolism
    18. TEWSON TJ; KROHN KA
      PET RADIOPHARMACEUTICALS - STATE-OF-THE-ART AND FUTURE-PROSPECTS

      Seminars in nuclear medicine
    19. LEHMANN HE; BAN TA
      THE HISTORY OF THE PSYCHOPHARMACOLOGY OF SCHIZOPHRENIA

      Canadian journal of psychiatry
    20. UNTERWALD EM; TSUKADA H; KAKIUCHI T; KOSUGI T; NISHIYAMA S; KREEK MJ
      USE OF POSITRON-EMISSION-TOMOGRAPHY TO MEASURE THE EFFECTS OF NALMEFENE ON D-1 AND D-2 DOPAMINE-RECEPTORS IN RAT-BRAIN

      Brain research
    21. BOWDEN C; THEODOROU AE; CHEETHAM SC; LOWTHER S; KATONA CLE; CROMPTON MR; HORTON RW
      DOPAMINE D-1 AND D-2 RECEPTOR-BINDING SITES IN BRAIN SAMPLES FROM DEPRESSED SUICIDES AND CONTROLS

      Brain research
    22. VANDERSCHYF CJ; DORMEHL IC; OLIVER DW; HUGO N; KEEVE R; MULLERGARTNER HW; POND SM; CASTAGNOLI N
      LONG-TERM TREATMENT WITH THE TETRAHYDROPYRIDINE ANALOG (HPTP) OF HALOPERIDOL INFLUENCES DOPAMINE LIGAND-BINDING IN BABOON BRAIN - AN [I-123] IODOBENZAMIDE (IBZM) SPECT STUDY

      Molecular brain research
    23. NEEDHAM PL; ATKINSON J; SKILL MJ; HEAL DJ
      ZOTEPINE - PRECLINICAL TESTS PREDICT ANTIPSYCHOTIC EFFICACY AND AN ATYPICAL PROFILE

      Psychopharmacology bulletin
    24. BRAND L; OLIVER DW; VANDERSCHYF CJ; POND SM; CASTAGNOLI N
      DOPAMINE-RECEPTOR BINDING OF UOROPHENYL)-4-OXOBUTYL]-1,2,3,6-TETRAHYDROPYRIDINE (HPTP), AN INTERMEDIATE METABOLITE OF HALOPERIDOL

      Life sciences
    25. KANES S; DAINS K; CIPP L; GATLEY J; HITZEMANN B; RASMUSSEN E; SANDERSON S; SILVERMAN M; HITZEMANN R
      MAPPING THE GENES FOR HALOPERIDOL-INDUCED CATALEPSY

      The Journal of pharmacology and experimental therapeutics
    26. MAJ J; DZIEDZICKAWASYLEWSKA M; ROGOZ R; ROGOZ Z; SKUZA G
      ANTIDEPRESSANT DRUGS GIVEN REPEATEDLY CHANGE THE BINDING OF THE DOPAMINE D-2 RECEPTOR AGONIST, [H-3] N-0437, TO DOPAMINE D-2 RECEPTORS IN THE RAT-BRAIN

      European journal of pharmacology
    27. TANIWAKI T; SHINODA H; KASEDA Y; KATO M; GOTO I
      INCREASED PREPROENKEPHALIN MESSENGER-RNA AND PREPROTACHYKININ MESSENGER-RNA IN THE STRIATUM OF ROLLING MOUSE NAGOYA

      Brain research
    28. HOLCOMB HH; CASCELLA NG; THAKER GK; MEDOFF DR; DANNALS RF; TAMMINGA CA
      FUNCTIONAL SITES OF NEUROLEPTIC DRUG-ACTION IN THE HUMAN BRAIN - PET FDG STUDIES WITH AND WITHOUT HALOPERIDOL/

      The American journal of psychiatry
    29. GRAY NS; PILOWSKY LS; GRAY JA; KERWIN RW
      LATENT INHIBITION IN DRUG-NAIVE SCHIZOPHRENICS - RELATIONSHIP TO DURATION OF ILLNESS AND DOPAMINE D2 BINDING USING SPET

      Schizophrenia research
    30. CHASE TN; METMAN LV; BRAVI D; ROBERTS JW; SIBLEY DR; MOURADIAN MM
      DOPAMINE-RECEPTOR SUBTYPE-SELECTIVE AGONISTS IN THE TREATMENT OF PARKINSONS-DISEASE

      Clinical neuropharmacology
    31. CLAUDI F; CINGOLANI GM; GIORGIONI G; CARDELLINI M; AMENTA F; POLIDORI C
      NEW 2-PYRIDYLETHYLAMINES WITH DOPAMINERGIC ACTIVITY - SYNTHESIS AND RADIOLIGAND-BINDING EVALUATION

      European journal of medicinal chemistry
    32. SEDVALL G; FARDE L
      CHEMICAL BRAIN ANATOMY IN SCHIZOPHRENIA

      Lancet
    33. CHATTERJEE A; CHAKOS M; KOREEN A; GEISLER S; SHEITMAN B; WOERNER M; KANE JM; ALVIR J; LIEBERMAN JA
      PREVALENCE AND CLINICAL CORRELATES OF EXTRAPYRAMIDAL SIGNS AND SPONTANEOUS DYSKINESIA IN NEVER-MEDICATED SCHIZOPHRENIC-PATIENTS

      The American journal of psychiatry
    34. VERMEULEN RJ; DRUKARCH B; VERHOEFF NPLG; GOOSEN C; SAHADAT MCR; WOLTERS EC; VANROYEN EA; STOOF JC
      NO DIRECT CORRELATION BETWEEN BEHAVIORALLY ACTIVE DOSES OF THE DOPAMINE D-2 AGONIST LY-171555 AND DISPLACEMENT OF [I-123] IBZM AS MEASURED WITH SPECT IN MPTP MONKEYS

      Synapse
    35. MORIARTY J
      THE VALUE OF SINGLE-PHOTON EMISSION TOMOGRAPHY IN PSYCHOPHARMACOLOGY

      Human psychopharmacology
    36. CARDELLINI M; CINGOLANI GM; CLAUDI F; DISTEFANO A; GIORGIONI G; CANTALAMESSA F; CAGNOTTO A; SKORUPSKA M
      SYNTHESIS AND EVALUATION OF 2-(5-METHOXYTHIOPHEN-3-YL)ETHYLAMINES AS POTENTIAL DOPAMINE AGONISTS

      European journal of medicinal chemistry
    37. KOUTOUZIS TK; BORLONGAN CV; SCORCIA T; CREESE I; CAHILL DW; FREEMAN TB; SANBERG PR
      SYSTEMIC 3-NITROPROPIONIC ACID - LONG-TERM EFFECTS ON LOCOMOTOR BEHAVIOR

      Brain research
    38. CURRAN EJ; ALBIN RL; BECKER JB
      ADRENAL-MEDULLA GRAFTS IN THE HEMIPARKINSONIAN RAT - PROFILE OF BEHAVIORAL RECOVERY PREDICTS RESTORATION OF THE SYMMETRY BETWEEN THE 2 STRIATA IN MEASURES OF PRESYNAPTIC AND POSTSYNAPTIC DOPAMINE FUNCTION

      The Journal of neuroscience
    39. NAGAYAMA H
      CHRONOPHARMACOLOGY OF PSYCHOTROPIC-DRUGS - CIRCADIAN-RHYTHMS IN DRUG EFFECTS AND ITS IMPLICATIONS TO RHYTHMS IN THE BRAIN

      Pharmacology & therapeutics
    40. MERCHANT KM; DORSA DM
      DIFFERENTIAL INDUCTION OF NEUROTENSIN AND C-FOS GENE-EXPRESSION BY TYPICAL VERSUS ATYPICAL ANTIPSYCHOTICS

      Proceedings of the National Academy of Sciences of the United Statesof America
    41. ASSIE MB; SLEIGHT AJ; KOEK W
      BIPHASIC DISPLACEMENT OF [H-3] YM-09151-2 BINDING IN THE RAT-BRAIN BYTHIORIDAZINE, RISPERIDONE AND CLOZAPINE, BUT NOT BY OTHER ANTIPSYCHOTICS

      European journal of pharmacology
    42. CALIGIURI MP; LOHR JB; JESTE DV
      PARKINSONISM IN NEUROLEPTIC-NAIVE SCHIZOPHRENIC-PATIENTS

      The American journal of psychiatry


ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 10/12/19 alle ore 01:31:02